Effects of omega-3 on depression: A systematic review
DOI:
https://doi.org/10.33448/rsd-v15i3.50696Keywords:
Fatty acids, Omega 3, Depression.Abstract
Objective: to evaluate the effects of omega-3 and find a consensus in the literature on dose/effectiveness. Methods: systematic review, with searches in databases and virtual libraries: Google Scholar, LILACS, MEDLINE/PubMed, Web of Science, and SciElo, using the terms "omega-3," "stress," and "oxidative stress." Conducted between January and March 2024. Studies that answered the guiding question "Does omega-3 improve depression?" were included. The Inclusion criteria were case-control studies in humans conducted in the last 5 years. Results: omega-3 improves depression and its symptoms. It was observed that the doses of EPA and DHA varied among the studies, but beneficial effects were observed even with low doses. Most studies used standardized questionnaires to measure the degree of depression and specific biomarkers for inflammation. Conclusion: omega-3 supplementation may be beneficial for the prevention and treatment of juvenile, senile, pre- and postpartum depression, closely relating it to inflammation. Future studies should focus on standardizing EPA and DHA dosages and consider the effects of supplement combinations. Omega-3 supplementation should be considered a necessary intervention to reduce the symptoms and occurrence of depression.
References
Borsini, A., Nicolaou, A., Camacho-Muñoz, D., Kendall, A. C., Di Benedetto, M. G., Giacobbe, J., Su, K.-P., & Pariante, C. M. (2021). Omega-3 polyunsaturated fatty acids protect against inflammation through production of LOX and CYP450 lipid mediators: relevance for major depression and for human hippocampal neurogenesis. Molecular Psychiatry, 26 (11), 6773-6788. https://doi.org/10.1038/s41380-021-01160-8
Carnegie, R., Araya, R., Ben-Shlomo, Y., Hemani, G., & Lewis, G. (2022). Omega-3 fatty acids and major depression: a mendelian randomization study. Translational Psychiatry, 14 (1), 222. https://doi.org/10.1038/s41398-024-02932-w
Chae, M., & Park, K. (2021). Association between dietary omega-3 fatty acid intake and depression in postmenopausal women. Nutrition Research and Practice, 15 (4), 468-478. https://doi.org/10.4162/nrp.2021.15.4.468
Chukaew, P., Leow, A., Saengsawang, W., & Rasenick, M. M. (2021). Potential depression and antidepressant-response biomarkers in human lymphoblast cell lines from treatment-responsive and treatment-resistant subjects: roles of ssris and omega-3 polyunsaturated fatty acids. Molecular Psychiatry, 26 (6), 2402-2414. https://doi.org/10.1038/s41380-020-0724-6
Ciesielski, T. H., & Williams, S. M. (2020). Low omega-3 intake is associated with high rates of depression and preterm birth on the country level. Scientific Reports, 10 (1), 19749. https://doi.org/10.1038/s41598-020-76552-x
Costello, L. A., Hartman, T. J., Wactawski-Wende, J., & O’Brien, K. O. (2024). Pre-pregnancy overweight or obesity moderates the association between prenatal maternal depression and infant cord blood omega-3 levels. BMC Pregnancy and Childbirth, 24 (1), 535. https://doi.org/10.1186/s12884-024-06732-4
Crossetti, M. G. O. (2012). Revisão integrativa de pesquisa na enfermagem: o rigor científico que lhe é exigido. Revista Gaúcha de Enfermagem, 33(2), 8–9. https://doi.org/10.1590/S1983-14472012000200001
Dyerberg, J., Madsen, P., Møller, J. M., Aardestrup, I., & Schmidt, E. B. (2010). Bioavailability of marine n-3 fatty acid formulations. Prostaglandins, Leukotrienes and Essential Fatty Acids, 83 (3), 137-141. https://doi.org/10.1016/j.plefa.2010.06.007
Gao, J., Liu, R., Wang, Y., Li, J., Zhao, Z., Zhang, Y., & Wang, X. (2024). Association between serum omega-3 pufas levels and cognitive impairment in never medically treated first-episode patients with geriatric depression: a cross-sectional Study. Journal of Affective Disorders, 346, 1-6. https://doi.org/10.1016/j.jad.2023.10.153
Li, S., Zhang, Y., Wang, Y., Liu, X., Zhao, J., & Wang, X. (2024). Omega-3 supplementation improves depressive symptoms, cognitive function and niacin skin flushing response in adolescent depression: a randomized controlled clinical trial. Journal of Affective Disorders, 345, 394-403. https://doi.org/10.1016/j.jad.2023.10.151
Lin, C., Su, K.-P., Huang, S.-Y., Chen, Y.-C., & Chang, J. P.-C. (2024). Cognitive protection and brain entropy changes from omega-3 polyunsaturated fatty acids supplement in late-life depression: a 52-week randomized controlled trial. Journal of Affective Disorders, 351, 15-23. https://doi.org/10.1016/j.jad.2024.01.205
Mac Giollabhui, N., Ellman, L. M., Coe, C. L., Byrne, M. L., Abramson, L. Y., & Alloy, L. B. (2023). Individuals with depression exhibiting a pro-inflammatory phenotype receiving omega-3 polyunsaturated fatty acids experience improved motivation-related cognitive function: preliminary results from a randomized controlled trial. Brain, Behavior & Immunity – Health, 32, 100666. https://doi.org/10.1016/j.bbih.2023.100666
Mac Giollabhui, N., Ellman, L. M., Coe, C. L., Byrne, M. L., Abramson, L. Y., & Alloy, L. B. (2024). Dysregulated inflammatory physiology and cognitive impairment in individuals with depression exhibiting a pro-inflammatory phenotype and receiving omega-3 polyunsaturated fatty acids. Psychoneuroendocrinology, 160, 106713. https://doi.org/10.1016/j.psyneuen.2023.106713
Madison, A. A., Kiecolt-Glaser, J. K., Malarkey, W. B., & Belury, M. A. (2023). Omega-3 fatty acids reduce depressive symptoms only among the socially stressed: a corollary of the social signal transduction theory of depression. Health Psychology, 42 (7), 448-459. https://doi.org/10.1037/hea0001301
Mehdi, S., Hassan, A., Ahmad, R., & Mahmood, T. (2023). Omega-3 fatty acids supplementation in the treatment of depression: an observational study. Journal of Personalized Medicine, 13 (2), 224. https://doi.org/10.3390/jpm13020224
Murphy, R. A., Devarshi, P. P., Ekimura, S., Marshall, K., & Mitmesser, S. H. (2021). Serum long chain omega-3 fatty acids and depression among adults in the united states: an analysis of NHANES 2011-2012. Journal of Affective Disorders Reports, 4, 100089. https://doi.org/10.1016/j.jadr.2021.100089
Nagayasu, Y., Suzuki, S., Yamashita, H., Kubota, T., & Takeda, S. (2021). Possible prevention of post-partum depression by intake of omega-3 polyunsaturated fatty acids and its relationship with interleukin 6. Journal of Obstetrics and Gynaecology Research, 47 (4), 1371-1379. https://doi.org/10.1111/jog.14592
National Institute of Mental Health. (2021). Depression: Overview. NIH. https://www.nimh.nih.gov/health/topics/depression
Okereke, O. I., Cook, N. R., Albert, C. M., Van Denburgh, M., Buring, J. E., & Manson, J. E. (2021). Effect of long-term supplementation with marine omega-3 fatty acids vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial. JAMA, 326 (23), 2385-2394. https://doi.org/10.1001/jama.2021.21187
Oravcova, H., Katrencikova, B., Garaiova, I., Durackova, Z., Trebaticka, J., & Jezova, D. (2022). Stress hormones cortisol and aldosterone, and selected markers of oxidative stress in response to long-term supplementation with omega-3 fatty acids in adolescent children with depression. Antioxidants, 11 (8), 1546. https://doi.org/10.3390/antiox11081546
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. Editora da UFSM. https://repositorio.ufsm.br/handle/1/15824
Risemberg, R. I. C., Silva, A. C. P., Souza, M. L., & Andrade, J. S. (2026). A importância da metodologia científica no desenvolvimento de artigos científicos. E-Acadêmica, 7(1), e0171675. https://eacademica.org/eacademica/article/view/675
Sikka, P., Behl, T., Kumar, A., Sehgal, A., Singh, S., & Bungau, S. (2021). Exploring the therapeutic potential of omega-3 fatty acids in depression. Environmental Science and Pollution Research International, 28 (32), 43021-43034. https://doi.org/10.1007/s11356-021-14884-5
Snyder, H. (2019). Literature review as a research methodology: An overview and guidelines. Journal of Business Research, 104, 333–339. https://doi.org/10.1016/j.jbusres.2019.07.039
Suneson, K., Lindqvist, D., Andiné, P., & Erhardt, S. (2024). Omega-3 fatty acids for inflamed depression: a match/mismatch study. Brain, Behavior and Immunity, 118, 192-201. https://doi.org/10.1016/j.bbi.2024.02.029
Thesing, C. S., Bot, M., Milaneschi, Y., Giltay, E. J., Penninx, B. W. J. H., & Kamphuis, M. H. (2020). Supplementation-induced increase in circulating omega-3 serum levels is not associated with a reduction in depressive symptoms: results from the moodfood depression prevention trial. Depression and Anxiety, 37 (11), 1079-1088. https://doi.org/10.1002/da.23092
van der Wurff, I. S. M., Meyer, B. J., de Groot, R. H. M., & Jolles, J. (2020). Exploring the association between whole blood omega-3 index, dha, epa, dpa, aa and n-6 dpa, and depression and self-esteem in adolescents of lower general secondary education. European Journal of Nutrition, 59 (2), 843-854. https://doi.org/10.1007/s00394-019-02175-2
World Health Organization. (2020). Depressive disorder (depression). WHO. https://www.who.int/news-room/fact-sheets/detail/depression
Wu, S.-K., Chen, W.-J., Chang, J. P.-C., Guu, T.-W., Hsin, M.-C., Huang, C.-K., Mischoulon, D., Capuron, L., & Su, K.-P. (2023). Personalized medicine of omega-3 fatty acids in depression treatment in obese and metabolically dysregulated patients. Journal of Personalized Medicine, 13(6), 1003. https://doi.org/10.3390/jpm13061003
Xue, Y., Zhang, Y., Liu, X., Yang, C., Wang, Y., & Zhao, J. (2024). Omega-3 polyunsaturated fatty acids supplementation improves memory in first-diagnosed, drug-naïve patients with depression: secondary analysis of a randomized controlled trial. Journal of Affective Disorders, 350, 403-410. https://doi.org/10.1016/j.jad.2024.01.149
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Larissa Souza de Oliveira, Marcos Souza Pinto de Carvalho
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
